Physician profile
Patrick Oley
NPI 1174986723
$3,722.40
in general payments reported to CMS, 2019-2025
27 companies · $7.58 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $383 · 2021: $886 · 2022: $1,874 · 2023: $309 · 2024: $263 · 2025: $7.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $997.60 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $900.99 | 2022 | |
| Medtronic USA, INC. | $286.16 | 2020 | |
| Nevro Corp. | $246.52 | 2021 | |
| Amgen INC. | $173.28 | 2021-2024 | |
| Abbott Laboratories | $147.77 | 2023 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.16 | 2021-2022 | |
| Lundbeck LLC | $109.50 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $94.25 | 2021-2022 | |
| Abbvie INC. | $92.53 | 2021-2022 | |
| Lilly USA, LLC | $76.44 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $74.56 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $56.99 | 2021 | |
| Radius Health, INC. | $48.14 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $47.79 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $45.52 | 2021 | |
| Relievant Medsystems, INC. | $42.29 | 2022 | |
| Fidia Pharma USA INC. | $18.05 | 2022 | |
| Allergan, INC. | $17.75 | 2021 | |
| Scilex Pharmaceuticals INC. | $17.54 | 2021 | |
| Baudax Bio INC. | $16.52 | 2021 | |
| Grt US Holding, INC. | $16.06 | 2022 | |
| Biodelivery Sciences International, INC. | $15.28 | 2021 | |
| Almatica Pharma LLC | $15.04 | 2021 | |
| Vertos Medical, INC. | $14.85 | 2021 | |
| Redhill Biopharma INC. | $14.24 | 2021 | |
| Mml US, INC. | $7.58 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Oley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.